4//SEC Filing
Matthews Judith M. 4
Accession 0001209191-22-018864
CIK 0001659323other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 5:01 PM ET
Size
9.1 KB
Accession
0001209191-22-018864
Insider Transaction Report
Form 4
Matthews Judith M.
Chief Financial Officer
Transactions
- Award
Ordinary Shares
2022-03-11+100,000→ 128,632 total - Sale
Ordinary Shares
2022-03-14$0.38/sh−47,132$17,910→ 81,500 total - Exercise/Conversion
Restricted Share Units
2022-03-11−100,000→ 100,000 total→ Ordinary Shares (100,000 underlying)
Footnotes (3)
- [F1]Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
- [F2]Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the RSUs. This sale does not represent a discretionary trade by the reporting person.
- [F3]On March 11, 2021, the reporting person was granted an award of 200,000 RSUs, 50% of which vested on March 11, 2022.
Documents
Issuer
Iterum Therapeutics plc
CIK 0001659323
Entity typeother
Related Parties
1- filerCIK 0001734033
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 5:01 PM ET
- Size
- 9.1 KB